Radiopharmaceuticals

As I write this, Telix Pharmaceuticals (TLX) is making headlines with a whopping 6.69% gain on the day, and investors are taking notice. But what’s behind this surge? Let me tell you – it’s not just about the numbers; it’s about the game-changing technology that’s driving this biotech powerhouse forward. Telix has been busy building … Read more